Sequent Scientific informs about investor presentation

17 Nov 2025 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that it enclosed Investor Presentation on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

215.65 -0.25 (-0.12%)
20-Feb-2026 11:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1287.65
Cipla 1330.45
Zydus Lifesciences 901.45
Lupin 2222.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×